| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2022 | -9.09% | B of A Securities | → $3 | Downgrades | Neutral → Underperform |
| 06/08/2022 | 21.21% | B of A Securities | $12 → $4 | Downgrades | Buy → Neutral |
| 10/19/2021 | 263.64% | HC Wainwright & Co. | $19 → $12 | Maintains | Buy |
| 10/08/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 10/06/2021 | 475.76% | HC Wainwright & Co. | $32 → $19 | Maintains | Buy |
| 10/04/2021 | — | Maxim Group | Downgrades | Buy → Hold | |
| 09/27/2021 | 354.55% | JP Morgan | → $15 | Initiates Coverage On | → Neutral |
| 06/18/2021 | 2930.3% | WBB Securities | $75 → $100 | Maintains | Strong Buy |
| 04/26/2021 | 869.7% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 02/01/2021 | 657.58% | UBS | → $25 | Initiates Coverage On | → Buy |
| 01/20/2021 | 930.3% | HC Wainwright & Co. | $31 → $34 | Maintains | Buy |
| 01/04/2021 | 839.39% | HC Wainwright & Co. | $32 → $31 | Maintains | Buy |
| 10/20/2020 | 536.36% | B of A Securities | → $21 | Initiates Coverage On | → Buy |
| 09/01/2020 | 263.64% | Wedbush | $17 → $12 | Maintains | Neutral |
| 08/21/2020 | 869.7% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 12/02/2019 | 930.3% | HC Wainwright & Co. | $35 → $34 | Reiterates | → Buy |
| 05/06/2019 | 687.88% | Cantor Fitzgerald | → $26 | Initiates Coverage On | → Overweight |
| 08/10/2018 | 869.7% | Maxim Group | $25 → $32 | Maintains | Buy |
| 05/17/2018 | 506.06% | Wedbush | $19 → $20 | Maintains | Neutral |
| 03/23/2018 | 657.58% | Maxim Group | $24 → $25 | Maintains | Buy |
| 03/23/2018 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 03/22/2018 | 657.58% | Maxim Group | $24 → $25 | Maintains | Buy |
Omeros Questions & Answers
The latest price target for Omeros (NASDAQ: OMER) was reported by B of A Securities on November 8, 2022. The analyst firm set a price target for $3.00 expecting OMER to fall to within 12 months (a possible -9.09% downside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Omeros (NASDAQ: OMER) was provided by B of A Securities, and Omeros downgraded their underperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omeros, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omeros was filed on November 8, 2022 so you should expect the next rating to be made available sometime around November 8, 2023.
While ratings are subjective and will change, the latest Omeros (OMER) rating was a downgraded with a price target of $0.00 to $3.00. The current price Omeros (OMER) is trading at is $3.30, which is out of the analyst's predicted range.